China Universal Asset Management Company’s Ventyx Biosciences VTYX Stock Holding History

China Universal Asset Management Company’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,628	Closed	-$195K	–	523
2025 Q4	$195K	Buy	+21,628	New	+$162K	0.02%	345
2024 Q4	–	Sell	-13,592	Closed	-$29.6K	–	524
2024 Q3	$29.6K	Buy	13,592 +5,310	+64%	+$12.2K	﹤0.01%	400
2024 Q2	$19.1K	Sell	8,282 -3,103	-27%	-$12.9K	﹤0.01%	391
2024 Q1	$62.6K	Buy	11,385 +4,553	+67%	+$20.8K	0.01%	401
2023 Q4	$16.9K	Buy	6,832 +5,326	+354%	+$50.6K	﹤0.01%	413
2023 Q3	$52.3K	Buy	1,506 +739	+96%	+$25.5K	0.02%	230
2023 Q2	$25.2K	Hold	767	–	–	0.01%	245
2023 Q1	$25.7K	Buy	767 +192	+33%	+$7.47K	0.01%	197
2022 Q4	$18.9K	Buy	+575	New	+$17K	0.01%	178

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

China Universal Asset Management Company's VTYX Position: Q1 2026 in Review

China Universal Asset Management Company sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 21,628 shares — an estimated $195K sold.

China Universal Asset Management Company first reported a position in VTYX in Q4 2022 and held it in 9 quarters. The position peaked at $195K in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

China Universal Asset Management Company reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
China Universal Asset Management Company sold 21,628 Ventyx Biosciences shares in Q1 2026, an estimated $195K.
China Universal Asset Management Company first reported a position in Ventyx Biosciences in Q4 2022 and held it in 9 quarters.
China Universal Asset Management Company's Ventyx Biosciences position peaked at $195K in Q4 2025.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.